Read transcripts of debates in both Houses
Produced by Commons Library, Lords Library and Parliamentary Office Science and Technology
Search for Members by name, postcode, constituency and party
Learn about their experience, knowledge and interests
A year-long programme of events, projects and resources
Discover what happens at the start of a new Parliament
Find out how you can get involved in the work of Parliament
Tickets for tours through to February 2016 are now available
Parliament is running 'Suffragette Season’ of events and tours
Book a school visit, classroom workshop or teacher-training session
Access videos, worksheets, lesson plans and games
Research Councils UK response to be published on 21 October 2014.
The World Health Organization (WHO) defines antimicrobial resistance (AMR) as resistance of a microorganism to an antimicrobial medicine to which it was originally sensitive. Resistant organisms (including bacteria, fungi, viruses and some parasites) are able to withstand antimicrobial medicines (such as antibiotics, antifungals, antivirals, and antimalarials) so that standard treatments become ineffective and infections persist, increasing the risk of spread to others. The development of AMR is a natural phenomenon but certain human actions accelerate the emergence and spread of AMR.
The scale of the threat of antimicrobial resistance (AMR) and the case for action was set out in the Annual Report of the Chief Medical Officer 2011, published in March 2013. The Government’s UK Five Year Antimicrobial Resistance Strategy 2013 to 2018 sets out actions to address the problem of AMR.
Science and Technology Committee publishes the Research Councils UK Response to the Committee's First Report of Session 2014–15
Government needs to set clear responsibilities in medicine to achieve better stewardship of antimicrobial drugs
Committee to publish report on Antimicrobial resistance on Monday 7 July
Committee to question Minister, Chief Medical Officer and Chief Veterinary Officer
Committee to discuss research and commercial development of antimicrobials
This is the third evidence session of the inquiry.
This is the second evidence session of the Antimicrobial resistance (AMR) inquiry.
Science and Technology Committee holds first evidence session on the science of AMR
The Science and Technology Committee has agreed to hold an inquiry into antimicrobial resistance